CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
APAC
CANADA

About Us

Conference

Partner With Us

  • Europe
    • US
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Biotech
    Cancer Immunotherapy
    Cell and Gene Therapy Companies
    Clinical Trial Management
    Drug Discovery and Development
    Genomics
    Therapeutics
    Women's Health
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    CDMO
    Clinical Laboratory Services
    CRO
    Supplements
  • Business Services
    Clinical Research Training
    Life Science Consulting
    Life Science Logistics
    Life Science Marketing
  • Leadership Perspectives
  • Innovation Insights
  • News
  • Magazines
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Clinical Net has been recognized by Life Sciences Review Magazine as the exclusive recipient of “Top 5 Biotech Startups in UK - 2022,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the Life Sciences Review research and editorial team based on insights from an interview with , .

Clinical Net
Making Clinical Trials Easily Accessible to Everyone

Clinical Net

NuriaCollBastus, founder and CEO , Clinical NetNuriaCollBastus, founder and CEO
Recruiting participants for clinical trials is a time-consuming and convoluted process for drug development organisations as well as clinical trial teams. Over 75 percent of clinical trials experience severe delays due to the lack of participants, which impedes the drug development process. At the same time, many people suffer because there isn’t treatment that can help their disease and don’t have access to safely use the innovative treatments being studied in clinical trials. This is the consequence of the absence of efficient patient recruitment solutions and a lack of easily accessible ways to find and connect to clinical trials.

This is where Clinical Net comes in with its worldwide clinical trial platform. The platform, to be launched in the last quarter of 2022, will address the biggest bottleneck in clinical trials: patient recruitment. Clinical Net’s global platform will help people access the most innovative treatments by easily connecting them with the most suitable clinical trials.

“Our industry-leading AI-driven algorithmic matchmaking technology will make it easier for patients, doctors, volunteers, or anyone to find the most suitable clinical trial in less than five minutes,” says Nuria Coll Bastus, founder and CEO, Clinical Net.

The platform leverages highly personalised questions generated by AI algorithms to find the relevant patients for specific clinical trials. It analyses the patterns in patient responses and draws relevant clinical insights, which are added to the clinical trial information pool. Based on this information pool, the platform matches patients to the appropriate trial and automatically connects them to the clinical trial teams.

By using revolutionising intelligent models, Clinical Net boosts trial participation, which benefits drug development organisations to reduce recruitment timelines at a fraction of the cost of any other solutions in the market. Being the first-ever global platform designed to make clinical trial information freely accessible to everybody within 5 minutes and efficiently boost clinical trial participation, Clinical Net is facilitating a shift in the world’s clinical trial paradigm by bringing new treatments to people in a faster way.

Clinical Net’s platform is designed to automate the entire patient recruitment process and accelerate drug development. It will eliminate the need for laborious manual searches and facilitate hassle-free recruitment. With this solution, healthcare professionals and investigators will no longer have to go through hospital databases to collect patient lists, identify suitable patients, or get in touch with them to enquire about their willingness to participate in the trials.

Along with connecting clinical trials teams with the right patients for trials, the platform will provide patients, their loved ones, and their healthcare providers with easy access to clinical trial information. The best part of this technology is that people don’t need to be aware of medical terminology to find a suitable trial. They don’t have to spend hours on Google searching through siloed information across multiple online databases. Clinical Net will allow patients to access the most suitable trial from over 50,000 options in a few clicks. The platform will free patients from the burden of calling up different clinical agencies to determine their eligibility for particular trials. Consequently, critical patients will be able to receive new drugs at the earliest, while pharma companies streamline production and enhance ROI.

Clinical Net will also ensure that healthy volunteers will be able to take part in specific clinical trials. The platform will have an easy-to-navigate user interface, allowing users to look for information and use the matching tool to find a suitable clinical trial.

Apart from these capabilities, Clinical Net platform will enable professionals working in drug development to find information on emerging therapies for research and competitor intelligence. This will be especially beneficial for those who surf through government websites for hours to find relevant information on clinical trials

Our industry-leading AI-driven algorithmic matchmaking technology will make it easier for patients, doctors, volunteers, or anyone to find the most suitable clinical trial in less than five minutes

Clinical Net expects to incorporate a “health module” into their platform by the first half of 2023. This module will allow anybody to automatically gather and structure their medical records currently scattered among multiple GP practices, clinics, and hospitals. This system will automatically request the importation of user's medical records from other entities following GDPR regulations, and will then extract and structure the medical terminology of the medical records. The structured medical records will be securely kept and readily available in the Clinical Net platform, from where the users will be able to use it to self-drive healthcare by combining them with the clinical trial matching tool of the Clinical Net platform to find the most suitable clinical trial for them, monitoring their health data over the years, and easily sharing their full medical record history during their medical appointments, allowing a faster and better diagnosis and treatment decisions. The Health module will be free to use for anybody to self-drive healthcare and attain early diagnosis, better treatment decisions, and access to the most innovative cost-free treatments. Altogether, this will reduce costs associated with missed/late diagnoses, erroneous treatments, and non-efficacious drugs.

The platform will certainly play a significant role in addressing the prevalent patient recruitment issues while making it easier for patients to get the life-saving medicine they need. With its platform, Clinical Net aims to create a paradigm shift in clinical drug development by making clinical trials accessible to the larger population.

Top 5 Biotech Startups in UK - 2022
Current Issue

Company : Clinical Net

Management
NuriaCollBastus, founder and CEO

Thank you for Subscribing to Life Science Review Weekly Brief

Life Sciences Review Europe
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review Europe. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://biotech-startups-europe.lifesciencesrevieweurope.com/vendor/making-clinical-trials-easily-accessible-to-everyone-cid-531-mid-55.html